secwatch.observer — SEC 8-K summary
======================================

Issuer:     ROCKWELL MEDICAL, INC. (RMTI)
CIK:        0001041024
Form:       8-K
Filed at:   2026-01-20T23:59:59+00:00
Accession:  0001628280-26-002478
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rockwell Medical prelim Q4 sales ~$18.6M; cash flow positive $2.3M
------------------------------------------------------------------

- Preliminary Q4 2025 net sales ~$18.6M; full-year 2025 ~$69.5M (audit pending).
- Gross margin improved to ~22% in Q4, up from 14% in Q3 2025.
- Q4 cash flow from operations ~$2.3M, second cash-positive quarter; cash & equivalents ~$25M at year-end.
- CEO highlighted revenue growth, increased profitability, and portfolio diversification as 2026 focus.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1041024/000162828026002478/0001628280-26-002478-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1041024/000162828026002478/rmti-20260120.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-002478

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer